Zhain Mustufvi

Dr. Zhain Mustufvi


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2022 in Rheumatology Advances in Practice
Verified
Journal Article
Open access
PDF file
ZMZhain Mustufvi
Zhain Mustufvi
JTJoshua Twigg
Joshua Twigg
JKJoel Kerry
Joel Kerry
JCJames Chesterman
James Chesterman
SPSue Pavitt
Sue Pavitt
KMKulveer Mankia
Kulveer Mankia
What does this mean for patients? This review found 21 research trials that investigated the effect of treatment of gum disease on rheumatoid arthritis. The key finding was that treating gum disease in people who have rheumatoid arthritis improves the DAS-28, which is a measure of the severity of the rheumatoid arthritis. This is important, because rheumatoid arthritis is incurable and has a significant impact on quality of life. Furthermore, gum disease is more prevalent in people with rheumatoid arthritis and, if untreated, can lead to pain, infection and premature tooth loss. This review highlighted several limitations of the included trials. In addressing these limitations, the review makes important recommendations for future research on this topic to ensure further high-quality findings. Finally, this review makes a strong case that rheumatologists, dentists and people who are affected by rheumatoid arthritis should have a heightened awareness of the link between these two diseases. Screening and treating gum disease should form part of the normal care pathway for people with rheumatoid arthritis.

10 February 2020 in BDJ In Practice
Verified
Journal Article
Closed access
PDF file
ZMZhain Mustufvi
Zhain Mustufvi
OBOlivia Barraclough
Olivia Barraclough
SHSimon Hearnshaw
Simon Hearnshaw
SWSandra Whiston
Sandra Whiston
SGSiobhan Grant
Siobhan Grant
GDGail Douglas
Gail Douglas

5 October 2021 in Healthcare
Verified
Journal Article
Open access
PDF file
ZMZhain Mustufvi
Zhain Mustufvi
SSStefan Serban
Stefan Serban
JCJames Chesterman
James Chesterman
KMKulveer Mankia
Kulveer Mankia
There is increasing evidence supporting an association between periodontal disease (PD) and rheumatoid arthritis (RA), both mechanistically and clinically. Trials have shown that treating PD in people with RA may improve RA disease activity. Patients with musculoskeletal symptoms without arthritis, who test positive for cyclic-citrullinated protein antibodies, are at risk of RA (CCP+ at-risk), with seropositivity preceding arthritis onset by months or years. Importantly, there is evidence to suggest that periodontal inflammation may precede joint inflammation in CCP+ at-risk and, therefore, this could be a trigger for RA. There has been increased research interest in RA prevention and the phenotyping of the pre-RA disease phase. This review will examine the merits of identifying individuals who are CCP+ at-risk and performing screening for PD. In addition, we discuss how PD should be treated once identified. Finally, the review will consider future research needed to advance our understanding of this disease association.